TVTX R&D Expenses
Travere Therapeutics Inc · R&D Expenses
TVTX R&D Expenses
Latest reported$227.14Mperiod ending
TVTX R&D Expenses ($0.00 → $227.14M)
Annual R&D Expenses
High-resolution chart · PNG
TVTX r&d expenses history
Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D Expenses (USD) |
|---|---|
| 206,011,000 | |
| 282,701,000 | |
| 244,990,000 | |
| 227,333,000 | |
| 201,159,000 | |
| 131,773,000 | |
| 140,963,000 | |
| 123,757,000 | |
| 78,168,000 | |
| 70,853,000 | |
| 50,426,000 | |
| 47,795,223 | |
| 7,084,009 | |
| 662,502 | |
| 0 | |
| 0 |